Parving HH - Search Results

1

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Gaede P, et al. Among authors: parving hh. N Engl J Med. 2003 Jan 30;348(5):383-93. doi: 10.1056/NEJMoa021778. N Engl J Med. 2003. PMID: 12556541 Free article. Clinical Trial.

2

Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy.

Sørensen VB, Rossing P, Tarnow L, Parving H, Nørgaard T, Kastrup J. Sørensen VB, et al. Clin Sci (Lond). 1998 Dec;95(6):709-17. doi: 10.1042/cs0950709. Clin Sci (Lond). 1998. PMID: 9831696 Clinical Trial.

3

Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy.

Jacobsen P, Andersen S, Rossing K, Hansen BV, Parving HH. Jacobsen P, et al. Among authors: parving hh. Nephrol Dial Transplant. 2002 Jun;17(6):1019-24. doi: 10.1093/ndt/17.6.1019. Nephrol Dial Transplant. 2002. PMID: 12032191 Clinical Trial.

4

PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients.

Jacobsen P, Grarup N, Tarnow L, Parving HH, Pedersen O. Jacobsen P, et al. Among authors: parving hh. Nephrol Dial Transplant. 2002 Aug;17(8):1408-12. doi: 10.1093/ndt/17.8.1408. Nephrol Dial Transplant. 2002. PMID: 12147787

5

Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy.

Parving HH, Hovind P. Parving HH, et al. Curr Hypertens Rep. 2002 Oct;4(5):387-93. doi: 10.1007/s11906-002-0069-3. Curr Hypertens Rep. 2002. PMID: 12217258 Review.

6

Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion rate.

Gaede P, Hansen HP, Parving HH, Pedersen O. Gaede P, et al. Among authors: parving hh. Nephrol Dial Transplant. 2003 Mar;18(3):539-42. doi: 10.1093/ndt/18.3.539. Nephrol Dial Transplant. 2003. PMID: 12584276 Clinical Trial.

7

Comparative effects of Irbesartan on ambulatory and office blood pressure: a substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria study.

Rossing K, Christensen PK, Andersen S, Hovind P, Hansen HP, Parving HH; Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study. Rossing K, et al. Among authors: parving hh. Diabetes Care. 2003 Mar;26(3):569-74. doi: 10.2337/diacare.26.3.569. Diabetes Care. 2003. PMID: 12610003 Clinical Trial.

8

Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.

Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH. Hovind P, et al. Among authors: parving hh. Diabetes Care. 2003 Apr;26(4):1258-64. doi: 10.2337/diacare.26.4.1258. Diabetes Care. 2003. PMID: 12663607

9

Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.

Jacobsen P, Andersen S, Rossing K, Jensen BR, Parving HH. Jacobsen P, et al. Among authors: parving hh. Kidney Int. 2003 May;63(5):1874-80. doi: 10.1046/j.1523-1755.2003.00940.x. Kidney Int. 2003. PMID: 12675866 Free article. Clinical Trial.

10

Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.

Rossing K, Jacobsen P, Pietraszek L, Parving HH. Rossing K, et al. Among authors: parving hh. Diabetes Care. 2003 Aug;26(8):2268-74. doi: 10.2337/diacare.26.8.2268. Diabetes Care. 2003. PMID: 12882847 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

668 results

Search Page